INBS

Intelligent Bio Solutions Inc.
CAPPED RATING

Intelligent Bio Solutions Inc. (INBS) is rated C (2.5/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (D).

Quantitative Factor Evaluation • Updated

Overall Rating
2.5 / 5.0
C
Value
B
Factor Score 3.3 / 5.0
Growth
B
Factor Score 3.2 / 5.0
Profitability
D+
Factor Score 1.8 / 5.0
Momentum
D
Factor Score 1.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 6.0
EV / EBITDA -0.4
Rev Growth YoY 35.8%
Gross Margin 48.6%
Price Return 3M -30.0%
Price Return 12M -73.3%
Catalyst Signal 0.00
Market Cap $7.0M
TTM Revenue $4.2M
Price / Sales 1.7
ROE -307.7%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 B (3.3) B (3.2) D+ (1.8) D (1.4) C+ (2.6) C (2.5)
2026-11-05 B (3.3) B (3.3) C- (1.9) C- (2.0) C+ (2.7) C+ (2.6)
2026-10-29 B (3.4) B (3.2) C- (1.9) C (2.2) C+ (2.7) C+ (2.7)
2026-10-22 B (3.3) B (3.2) C- (1.9) C- (2.0) C+ (2.6) C+ (2.6)
2026-10-15 B (3.3) B (3.2) C- (1.9) D+ (1.5) C+ (2.6) C+ (2.5)
Page 1 of 4